The effects of sacubitril/valsartan compared to valsartan in experimentally induced chronic kidney disease. [PDF]
Naunyn Schmiedebergs Arch PharmacolAl Maskari R +4 more
europepmc +1 more source
The NPR1 agonist antibody XXB750 in heart failure: a phase 2 randomized trial. [PDF]
Nat MedSolomon SD +11 more
europepmc +1 more source
Correction: Short-term effects of sacubitril/valsartan on echocardiographic parameters in dogs with symptomatic myxomatous mitral valve disease. [PDF]
Front Vet SciSaengklub N +4 more
europepmc +1 more source
TangShenWeiNing formula alleviates diabetic kidney disease by inhibiting ferroptosis via AMPK pathway in renal tubular epithelial cells. [PDF]
Front Endocrinol (Lausanne)Jiang Y, Chang J, Guo Y, Liu Z, Feng X.
europepmc +1 more source
Efficacy and Safety of Sacubitril/Valsartan Versus Enalapril in the Treatment of Heart Failure With Reduced Ejection Fraction: A Systematic Review and Meta-Analysis. [PDF]
CureusAljubeh R +6 more
europepmc +1 more source
Metabolic alterations associated with sacubitril/valsartan treatment: a systematic review and meta-analysis. [PDF]
BMC Cardiovasc DisordAbhari AP +6 more
europepmc +1 more source
Impact of sacubitril/valsartan on cardiac structure and function in post-acute myocardial infarction heart failure patients aged over 65: a single-center experience. [PDF]
Am J Transl ResYang L +9 more
europepmc +1 more source
A Comprehensive Physicochemical Analysis Focusing on the Characterization and Stability of Valsartan Silver Nano-Conjugates. [PDF]
Int J Mol SciQadir A +13 more
europepmc +1 more source
Sacubitril/valsartan facilitates recovery of cardiac function in a patient with peripartum cardiomyopathy: a case report. [PDF]
Eur Heart J Case RepSaijo Y +4 more
europepmc +1 more source
Reply to 'Sacubitril/valsartan in heart failure: a critical look at dementia risk and future study pathways'. [PDF]
Eur Heart J Cardiovasc PharmacotherJung K, Shin JY, Kim JH.
europepmc +1 more source